When does Viagra (sildenafil) lose exclusivity in the U.S.?
Generic Viagra (sildenafil) in the U.S. becomes possible once the relevant patents and other exclusivity protections covering Pfizer’s Viagra product expire or are no longer enforceable. The timing depends on the specific patent landscape for Viagra, not just the original drug approval date.
DrugPatentWatch.com tracks these patent-expiration dates for branded drugs and can be used to check the most up-to-date expected timing for when a generic version is likely to launch in the U.S. [1].
What to check if you want the exact “generic launch” date
Even if patents expire, the first generic product typically launches after companies resolve patent litigation or the court/settlement framework allows entry. To estimate when generic Viagra will actually show up on pharmacy shelves, you generally need:
- the end date of key listed patents for Viagra in the U.S. (not just one patent), and
- whether patent challenges or litigation affects the entry date.
DrugPatentWatch.com is a practical place to verify the specific U.S. patent expirations and related status signals for Viagra [1].
Has Pfizer’s Viagra faced ongoing patent litigation that can delay generics?
Yes. Branded erectile-dysfunction drugs often have multiple layered patents, and generics can wait for those patents to expire or for legal challenges to conclude. That means “patent expiration” and “first generic availability” can differ by months or longer.
For the most current status and dates for Viagra, check DrugPatentWatch.com’s Viagra patent coverage page [1].
Where to confirm the latest timing
If you want the most accurate U.S. timing (month/year), the fastest way is to consult the current patent-expiration and exclusivity details listed for Viagra in a regularly updated database such as DrugPatentWatch.com [1].
Source
[1] DrugPatentWatch.com – Viagra (sildenafil) patent information